电视胸腔镜手术诊治恶性胸腔积液

目的:探讨电视胸腔镜手术(VATS)诊治恶性胸腔积液的安全性和效果。方法:自2001年6月至2002年6月对7例胸腔病人实施了VATS诊治。均行胸腔活检、滑石粉喷洒胸腔固定术。结果:6例获得明确的病理诊断,4例为癌胸膜转移,2例为恶性间皮细胞瘤。1例未明确诊断,无术后严重并发症和死亡。随访1～8个月,胸腔积液均得到控制,未见复发。结论:电视胸腔镜手术在诊治恶性胸水方面有明显的优点。     

电视纵隔镜在恶性胸腔积液诊治中的应用

目的探讨电视纵隔镜在诊治恶性胸腔积液中的应用价值。方法回顾分析自2003年10月至2004年4月12例恶性胸腔积液患者行电视纵隔镜胸膜活检+滑石粉胸膜固定术治疗的临床资料。结果术后病理诊断腺癌8例,鳞癌4例;肺癌胸膜转移11例,食管癌肺、胸膜转移1例;手术诊断率100%,有效率91.7%(11/12),全组无手术死亡。术后发生低热3例,经处理后退热;胸痛3例,经止痛后缓解。结论电视纵隔镜对恶性胸腔积液的诊断和治疗有良好的临床效果。     

电视胸腔镜手术诊治255例不明原因胸腔积液

目的 探讨电视辅助胸腔镜手术（video assisted thoracoscopic surgery,VATS）对胸腔积液的诊治价值。方法 回顾分析1995年3月～2005年12月255例不明原因胸腔积液经电视胸腔镜手术的临床资料。均经双腔气管插管静吸复合全麻,健肺单肺通气。对包裹形成者先做包裹分离,然后吸尽胸腔积液,再探查有无胸膜结节及肺部结节或肿块,对可疑病灶多点取材做冰冻切片活检。肺复张不完全者,进行纤维板剥脱术。根据病理结果采取胸腔冲洗、胸膜固定及胸腔内化疗等处理方法。结果 255例均经术中冰冻病理检查确诊,其中57例恶性,153例结核性,45例炎性。全组无术中并发症。手术时间60～140min,平均97min。出血量100～850ml,平均226ml。术后222例肺膨胀完全,33例因肿瘤压迫肺膨胀不完全。恶性胸腔积液患者术后随访存活者14例,存活时间12～20个月,平均16.8个月,其余43例在6～12个月内死亡。结核性胸腔积液者142例随访2年,2例在术后1年左右复发,经胸穿治疗好转。炎性胸腔积液41例随访1年无复发。结论 电视胸腔镜在胸腔积液的处理中具有快速、安全、微创、准确诊断等优点,是有效的治疗手段。     

可曲式内科电子胸腔镜在不明原因胸腔积液诊断中的应用

目的探讨可曲式内科电子胸腔镜在不明原因渗出性胸腔积液诊断中的应用价值。方法回顾性总结2007年11月至2008年11月行可曲式内科电子胸腔镜检查的不明原因渗出性胸腔积液病例28例，分析可曲式内科电子胸腔镜检查的诊断效率及并发症等。结果28例不明原因胸腔积液患者经可曲式内科电子胸腔镜检查后，25例（89％）最终确诊，其中肺癌胸膜转移18例，恶性胸膜问皮瘤1例，卵巢癌胸膜转移1例；结核性胸膜炎5例；3例未能明确诊断。28例患者在可曲式内科电子胸腔镜检查术中、术后无严重不良反应发生。结论可曲式内科电子胸腔镜在不明原因胸腔积液的诊断中具有重要的应用价值：     

电视胸腔镜在不明原因胸腔积液诊治中的价值

目的评价电视胸腔镜在不明原因胸腔积液诊治中的价值。方法2002年3月～2005年3月对常规检查无法明确病因的45例胸腔积液在电视胸腔镜下完成活检或纤维板剥脱、胸膜固定。结果45例全部确诊，其中恶性3例，结核性胸腔积液38例，非特异性胸腔积液3例，特发性胸腔积液1例。45例随访2～36个月，平均18个月，无胸腔积液复发。结论电视胸腔镜手术诊治胸腔积液具有诊断率高、安全、准确、损伤小的特点。     

胸腔镜检查在胸腔积液诊断中的价值

目的　评价胸腔镜检查对疑难胸腔积液的诊断价值。　方法　 4 5例胸腔积液行胸腔镜检查 ,直视下取病变组织行病理检查。　结果　确诊胸膜转移癌 2 5例 ,胸膜间皮瘤 1例 ,胸膜结核 4例 ,结节病 1例 ,非特异性炎症 10例 ,胸腔镜诊断率为 91.1% (41/ 4 5 )。胸膜间皮瘤、转移癌、结核性胸膜炎胸腔镜下形态不同。无严重并发症。　结论　胸腔镜检查对胸腔积液是一种安全、有效、诊断率高的检查手段。     

电视胸腔镜手术治疗恶性胸腔积液37例临床分析

目的探讨电视胸腔镜手术治疗恶性胸腔积液的方法,总结其临床经验。方法回顾性分析2009年1月至2011年12月宝鸡市中心医院37例恶性胸腔积液患者的临床资料,男21例、女16例,年龄43～75岁。其中肺癌15例,乳腺癌7例,食管癌7例,胃癌4例,胸膜间皮瘤3例,卵巢癌1例;均为单侧胸腔积液,其中左侧胸腔积液22例,右侧胸腔积液15例。所有患者均行电视胸腔镜手术（VATS）或VATS辅助小切口完成手术,在电视胸腔镜下行胸膜剥脱术,并喷洒滑石粉固定胸膜。结果围术期无死亡,7例（18.9%）延长切口,手术时间（40.32±19.06）min,术中出血量（90.09±41.03）ml,术后（7.31±2.08）d拔除胸腔引流管,术后住院时间（9.02±3.11）d。手术有效率100%,其中完全缓解19例（51.4%）。术后出现轻度并发症,如肺部感染、持续性漏气和切口感染等,经对症处理治愈。结论电视胸腔镜治疗恶性胸腔积液是一种微创、有效、实用的治疗方法。     

电视胸腔镜对恶性胸水治疗探讨

目的:探讨电视胸腔镜对恶性胸水的手术治疗效果。方法:回顾性分析33例恶性胸腔积液电视胸腔镜手术治疗效果。本组病例33例,30例术前有不同程度的胸闷气喘。病史5周～10个月,单侧胸水28例,双侧胸水5例,大量胸水者11例,中等量胸水者19例,少量胸水者3例,全组病例术前均行胸穿抽液,平均抽液量1500ml,血性胸水30例,草黄色胸水3例。11例术前曾行针刺胸膜活检术,可疑癌性胸水3例。结果:33例患者,14例术前已明确原发癌灶,余19例术中均经病理检查确诊为恶性胸腔积液,其中肺腺癌18例,肺鳞癌9例,肺未分化癌1例,乳腺癌肺转移2例,转移性卵巢癌3例。全组病例均行喷洒滑石粉胸膜固定术,获得永久的完全胸膜固定,术后第2天胸引量明显减少,术后置胸引管约3～8天,平均4天,术后平均引量270ml。胸透证实肺复张后拔胸引管。结论:电视胸腔镜对恶性胸水是一种重要的定性检查和治疗手段,值得临床上广泛应用。     

胸腔镜在恶性胸腔积液治疗中的应用价值

目的探讨电视胸腔镜在胸腔积液病因诊断及治疗中的价值。方法 2009年7月~2015年11月对27例疑似恶性胸腔积液,经胸腔镜探查行肿物活检及胸膜固定术。结果 27例均确诊,其中原发肺癌18例,肺外转移癌9例。均未出现严重并发症。术后第4周胸部X线片示CR 16例(肺癌胸膜转移13例,转移癌3例),PR 9例(肺癌胸膜转移3例,转移癌6例),SD 2例(均为肺癌胸膜转移),有效率92.6%(25/27)。结论电视胸腔镜在胸腔积液病因诊断及治疗中具有较高价值。     

经肋间电视纵隔镜手术701例临床分析

目的探讨经肋间电视纵隔镜手术在纵隔肿物、恶性胸腔积液和手汗症诊治中的应用。方法回顾性分析2001年11月至2007年6月我院收治的701例经肋间电视纵隔镜手术患者的临床资料。其中术前未获得明确病理诊断的纵隔肿物患者48例和恶性胸腔积液患者46例,经肋间电视纵隔镜手术行纵隔肿物或胸膜活检,39例行滑石粉胸膜固定术;手汗症患者607例,行双侧胸交感神经链切断术。结果本组无手术死亡和严重并发症。48例纵隔肿物、46例临床诊断恶性胸腔积液患者,经肋间电视纵隔镜手术全部获得明确病理诊断。39例恶性胸腔积液患者行滑石粉胸膜固定术,成功率100％。607例手汗症患者术后手汗症状均完全消失,手掌温度上升1．5～3．0℃,温暖干燥,随访尚无患者复发。结论经肋间单一切口电视纵隔镜手术对于纵隔肿物、恶性胸腔积液和手汗症是一种简便有效的诊治手段。     

Usefulness of thoracoscopic surgery in the diagnosis and management of thoracic diseases

BACKGROUND: Video-assisted thoracoscopic surgery (VATS) has been recently utilised in the diagnosis and management of thoracic diseases. In this article we report our series of patients with established indications for VATS treatment. METHODS: Over the past 6 years we performed 104 VATS procedures for diagnostic and therapeutic purposes in 95 men and 39 women. The specific indications for VATS were: lung biopsy for undiagnosed diffuse lung disease, mediastinal biopsy and cysts, pleural effusion, empyema, pneumothorax and bullous lung disease, pericardial effusion and cyst, parvertebral abscess and solitary pulmonary nodules. RESULTS: There was no operative mortality. Postoperative non-fatal complications were seen in 7 cases. The overall median duration of chest tube drainage was 2.5 days and the mean postoperative stay 3 days. In diffuse lung disease a tissue diagnosis was obtained in all cases. Definitive diagnosis in the patients with undiagnosed pleural effusion was obtained in 90% of cases and the overall diagnostic rate was 98.5%. The success rate of the empyema (stage II) treatment and the therapeutic procedures is 100% after a mean follow-up of 12 months (range 6-30). Conversion to thoracotomy was needed in 6 cases. In all patients the postoperative pain was controlled with intake of non-narcotic analgesics with satisfactory results. CONCLUSIONS: VATS is worth considering and has been established as procedure of choice, with exceptional results in various chest diseases such as undiagnosed pleural effusions, recurrent, post-traumatic or complicated spontaneous pneumothorax, stage II empyema, accurate staging for lung cancer in the resection of peripheral solitary pulmonary nodule less than 3 cm, and lung biopsy for pulmonary diffuse disease.     

Long-term follow-up of video-assisted talc pleurodesis in malignant recurrent pleural effusions.

OBJECTIVE: Recurrent pleural effusion is a common condition and often presents a challenge for treatment. The aim of this report is to evaluate the long-term follow-up of thoracoscopic management of malignant recurrent pleural effusions. METHODS: From July 1st, 1992 to February 28th, 2001, out of 2311 VATS procedures performed at our Institution, 690 patients (29.85%) underwent videothoracoscopy (VATS) for recurrent pleural effusion. Of these 611 (88.55%) were treated for a malignant pleural effusion. There were 374 male and 237 female, with a mean age of 61.2 years. In all patients VATS was performed under general anaesthesia. The pleural effusion was carefully aspirated; fibrinous adhesions were taken down while dense fibrous adhesions were selectively divided; some limited decortications were also performed. Multiple pleural biopsies were always performed. Pleurodesis was performed with 5 g of sterile purified talc insufflated through a talc atomizer. One chest tube was left in situ for 3-5 days. RESULTS: Operative mortality was 0.81% (five cases). Postoperative complications occurred in 19 cases (3.1%). Specific histologic diagnosis was obtained in all patients. Follow-up was available for 602 patients (98.5%). After a median follow-up of 64 months (range 5-105 months), talc pleurodesis was successful in controlling recurrence of effusion in 92.7% (558 out of 602) of patients. The success rate did not show any statistically significant difference between patients who underwent postoperative adjuvant therapy and patients who did not. In two patients with failure of talc pleurodesis a redo-VATS was performed. CONCLUSIONS: VATS represents the method of choice for both diagnosis and treatment of malignant recurrent pleural effusions. Talc poudrage is safe and effective in obtaining pleurodesis.     

Primary papillary serous carcinoma of the peritoneum diagnosed by video-assisted thoracoscopic surgery: Report of a case

A 53-year-old woman who had end-stage renal disease and hypertension presented with back pain. Chest radiographs and chest computed tomography (CT) showed right pleural effusion with bilateral pleural masses. The patient underwent video-assisted thoracoscopic surgery (VATS) for a biopsy of the right pleural mass and for an evaluation of pleural effusion. A frozensection specimen suggested a papillary adenocarcinoma, which was confirmed to be metastatic primary papillary serous carcinoma of the peritoneum by immunohistochemistry, an elevated serum cancer antigen (CA-125) level, and abdominal CT findings. We found that the patient had been unfortunately misdiagnosed to have advanced colon cancer 11 years previously and thus had undergone a right hemicolectomy which was followed by six cycles of 5-fluorouracil chemotherapy. Despite this, she survived more than 10 years and was later correctly diagnosed by VATS of the pleural lesions and based on a review of the previous pathology. The patient was transferred to an oncologist to receive the proper chemotherapy with paclitaxel and carboplatin.     

Video-assisted thoracoscopic surgery in the diagnosis and treatment of chest diseases

Video-assisted thoracoscopic surgery (VATS) has been used recently in the diagnosis and management of thoracic diseases. In this report, VATS experience with 95 cases, focusing on indications, surgical procedures, complications, and failure rates, are reviewed. Over the past 5 years, 95 VATS procedures for diagnostic and therapeutic purposes were performed in 59 men and 36 women. The specific indications for VATS were lung biopsy for undiagnosed diffuse lung disease (48), mediastinal biopsy (12) and cyst (2), pleural effusion (10), empyema (5), pneumothorax and bullous lung disease (6), pericardial effusion (2) and cyst (2), paravertebral abscess (2), solitary pulmonary nodules (3), and thoracic trauma (3). In all patients, postoperative pain was controlled with non-narcotic analgesics and was measured according to the visual analogue scale (VAS). There was no surgical mortality. Postoperative nonfatal complications were seen in seven cases (7.5%). The overall median duration of chest tube drainage was 2.7 days and the mean postoperative hospital stay was 3 days. For diffuse lung disease, a tissue diagnosis was obtained in all the cases. Definitive diagnosis in the patients with undiagnosed pleural effusion was obtained in 90% of cases, and the overall diagnostic rate was 98.5%. The success rate of the therapeutic procedures was 100% after a mean follow-up of 12 months (range, 6-30 months). Conversion to thoracotomy was needed in six cases (6.6%). All patients scored postoperative pain <50% according to the VAS. Video-assisted thoracoscopic surgery should be considered as a procedure of choice, with exceptional results in the following chest diseases: (a) undiagnosed pleural effusions; (b) recurrent, post-traumatic, or complicated spontaneous pneumothorax; (c) stage II empyema; (d) accurate staging of lung cancer; (e) emergency traumatic injuries of the chest; (f) peripheral solitary pulmonary nodule <3 cm; and (g) lung biopsy for pulmonary diffuse disease.     

胸腔镜在恶性胸腔积液诊治中的应用

自１９９２年１１月至１９９６年１０月间,作者用胸腔镜技术对２０例恶性胸腔积液患者进行了诊断和治疗,均获得明确诊断;其中恶性胸膜间皮瘤８例,转移癌１２例。２０例行滑石粉胸膜固定术;其中１８例获得可靠的胸膜固定。有２例未成功的原因为肺实性变而不能复张。术后有２例短暂发热和轻度哮喘,对症治疗后症状明显缓解。作者认为,胸腔镜手术可以大大提高恶性胸腔积液的病因诊断率和胸膜固定术的效果,术中应尽可能将附着于脏、壁层胸膜的纤维素剥除,以利于肺复张。     

Comparative analysis of chest tube thoracostomy and video-assisted thoracoscopic surgery in empyema and parapneumonic effusion associated with pneumonia in children

BACKGROUND: Controversy exists regarding the optimal management strategy for children having empyema or parapneumonic effusion as a complication of pneumonia. We hypothesized that video-assisted thoracoscopic surgery (VATS)-assisted drainage of pleural fluid and debridement of the pleural space is superior to a chest tube alone in the management of these patients. We further identified predictive factors-namely, presentation, radiographic findings, antibiotic usage, and pleural fluid features-that could predict the need for VATS rather than primary chest tube drainage. METHODS: Forty-nine pediatric patients with pneumonia complicated by parapneumonic effusion or empyema treated at the Children's Hospital of Pittsburgh (1997-2003) were divided into three groups according to the therapy instituted: Primary chest tube, chest tube followed by VATS, or primary VATS. The groups were analyzed in terms of demographics and outcome, as judged by pleural fluid analysis and hospital resource utilization. Demographic and outcome data were compared among groups using one-way analysis of variance and the Student t-test. RESULTS: All groups were similar with respect to demographics and initial antibiotic usage. Patients undergoing primary VATS had a higher initial temperature, whereas radiographic findings of mediastinal shift and air bronchograms were more likely to be found in patients who underwent primary chest tube placement. Patients undergoing primary VATS demonstrated a significantly shorter total stay and lower hospital charges than the other groups. Forty percent of children started on chest tube therapy failed even with subsequent VATS, necessitating a significantly longer hospital course (18 +/- 3 vs. 11 +/- 0.8 days; p < 0.05) and higher hospital charges ($50,000 +/- 7,000 vs. $29,000 +/- 1000) than those having primary VATS. CONCLUSIONS: Patients treated by primary VATS had a shorter stay and lower hospital charges than patients treated by chest tube and antibiotic therapy alone. There were no demographic, physiologic, laboratory, or chest radiographic data that predicted the selection of VATS as an initial treatment. These data suggest a strategy of primary VATS as first-line treatment in the management of empyema or parapneumonic effusion as a complication of pneumonia in pediatric patients.     

Single-incision thoracoscopic surgery of pleural effusions for diagnosis and treatment

Background

Several procedures such as video-assisted thoracoscopic surgery (VATS) are used to make a definite diagnosis in recurrent pleural effusions so that appropriate treatment can be arranged. Single-incision thoracoscopic surgery (SITS) is the most appropriate procedure that can be used for this purpose. The contribution of SITS to diagnosis and treatment is evaluated in this study that we conducted using a single thoracoport in patients with pleural effusion.

Methods

Nineteen consecutive patients with pleural effusion that was recurrent or refractory to medical treatment were included in the study to be diagnosed and treated with SITS. Thoracentesis was performed and pleural fluid samples obtained in all patients before the procedure. Pleural effusion drainage was performed from the 11-mm single skin incision by using a 10.5-mm single thoracoport, and biopsy or talc pleurodesis was performed in the same session when needed.

Results

The median age of the patients was 56.68 ± 3.05 years and there were 11 males and 8 females. The total amount of fluid drained by SITS was 1,436 ± 227 mL and the surgery lasted 81.05 ± 5.36 min. In addition, partial decortication and/or deloculation were performed in six patients and talc pleurodesis in nine patients. Fifteen patients were diagnosed with benign and four patients with malignant pleural effusion by thoracentesis, while nine patients were diagnosed with benign and ten patients with malignant pleural effusion by SITS. We therefore had six cases diagnosed as benign with thoracentesis who were diagnosed with malignant disease after SITS.

Conclusions

SITS presents both diagnosis and treatment options together for pleural effusions. We believe SITS should be preferred to conventional three-port VATS to minimize the spread of infection and tumor cells to the chest wall in infectious and malignant diseases.     

Thoracoscopic surgery for diseases of the lung and pleura. Effectiveness, changing indications, and limitations.

OBJECTIVE: This study compared the results of video-assisted thoracic surgery (VATS) with thoracoscopic surgery (TS) for diseases of the lung and pleura. SUMMARY BACKGROUND DATA: No studies exist that compare the capabilities of VATS with advanced video systems and instrumentation to that of TS which has been done for 80 years. METHODS: A retrospective study was done comparing the effectiveness, indications, complications, and limitations of TS and VATS done for four categories of pleural disease: 1) pleural fluid problems, 2) diffuse lung disease, 3) lung masses, and 4) pneumothorax. The TS period was 1981-1990. The VATS period was 1991-1992. RESULTS: Eighty-nine consecutive TS cases and 64 consecutive VATS cases were reviewed. TS for resolution of pleural fluid problem was successful in 29 of 34 patients (85%), and VATS was successful in 18 of 20 (90%). Diffuse lung disease was diagnosed by TS using a cup biopsy on end-stage patients in respiratory failure. Since 1991 the diagnosis has been made with VATS using stapled wedge excisions on ambulatory patients. Surgical mortality decreased from 33% (10 of 30) to 9% (1 of 11) and the postoperative stay from 16.6 +/- 2.4 days to 8.2 +/- 2.2 days. Lung masses were diagnosed entirely by incisional biopsies using TS. Diagnosis was made in 83% and postoperative stay was 5.3 +/- 1.0 day. VATS allowed excisional biopsies permitting diagnosis in 100% with a postoperative stay of 3.0 +/- 0.2 days (p = 0.05). However, 20% required conversion to thoracotomy to locate the subpleural mass. TS was performed for spontaneous pneumothorax in only 26% (5 of 19) of the total pneumothorax cases, whereas, VATS was used for spontaneous pneumothorax in 67% (12 of 18). CONCLUSION: VATS has continued the effectiveness of TS for treating pleural fluid problems, has resulted in earlier surgical diagnostic intervention in diffuse lung disease and earlier therapeutic intervention in primary pneumothorax states, and has markedly expanded the safety, efficacy and indications for lung mass biopsy.     

Video-assisted thoracic surgery utilizing local anesthesia and sedation.

OBJECTIVE: Video-assisted thoracic surgery (VATS) is usually performed with general anesthesia and double-lumen endotracheal intubation, but minor procedures have been carried out with patients spontaneously breathing and with epidural or regional analgesia. We have broadened our indications for VATS utilizing purely local anesthesia and sedation. METHODS: The medical records of all patients undergoing VATS under local anesthesia and sedation at Geisinger Wyoming Valley Medical Center between 7/1/02 and 6/1/06 were reviewed. All procedures were performed in the operating room with patients in full lateral position; no patient had endotracheal intubation or epidural or nerve block analgesia. RESULTS: One hundred and fifteen patients, ranging in age from 21 to 88 years and in size from 40 to 172 kg, underwent 126 video-assisted thoracic operations: pleural biopsy/effusion drainage with or without talc 81, drainage of empyema 21, lung biopsy 18, evacuate hemothorax 3, pericardial window 2, biopsy chest wall mass 1. No patient required intubation or conversion to thoracotomy. Three patients who underwent lung biopsy died of their underlying disease (cytomegalovirus and pneumocystis, primary amyloidosis, metastatic cancer to contra-lateral lung) on postoperative days 18, 14, and 4, respectively. One patient developed transient renal insufficiency attributed to ketorolac. CONCLUSION: VATS utilizing local anesthesia and sedation is well tolerated, safe, and valuable for an increasing number of indications.